PHARMACEUTICAL ASSOCIATION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, USE OF RESVERATROL AND PROGESTOGEN, PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MYOMA AND/OR ENDOMETRIOSIS, MEDICAMENT FOR TREATING AND/OR PREVENTING
OA: closed
AI-generated summary
This patent discloses pharmaceutical compositions combining resveratrol and progestogens, optionally with estrogen, for treating or preventing myoma and endometriosis by reducing lesion dimensions and controlling associated symptoms.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The present invention relates to an association of resveratrol with progestogens, and to pharmaceutical compositions and medicaments containing same, useful for the treatment and/or prevention of myoma and/or endometriosis, reducing the dimensions thereof and controlling the associated symptoms. This association can additionally contain an estrogen component. Also disclosed are a method for treatment and a kit.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-08-01T06:07:04.264727+00:00